Australia National Pathology Standards (First Edition 2027)
Standard 10: Specimen testing – Australia National Pathology Standards (First Edition 2027)

Australia National Pathology Standards (First Edition 2027) 10.03: Measurement uncertainty process: for quantitative assays define the measurand, indicate the laboratory's confidence in each measurement, provide information for interpreting results and comparing them over time, set clinically appropriate imprecision goals, identify significant uncertainty sources and reduction opportunities, and use statistically adequate replicate numbers or statistical methods that account for fewer replicates

What does 10.03 require?

Measurement uncertainty is estimated for quantitative assays by a process that states what quantity is being measured, expresses how confident the laboratory is in each measurement, gives what is needed to interpret results and compare them over time, sets imprecision goals that make clinical sense, finds the main contributors to uncertainty and ways to shrink them, and rests on enough replicate measurements for statistical validity or on statistics that allow for fewer replicates.

Maintained by Gerard Blokdyk

What else in your programme already covers this

This control maps to 1 controls across 1 other frameworks. If you already hold one of them, the evidence you collected for it is the starting point here rather than new work.

  • 7.3.4 7.3.4 Evaluation of measurement uncertainty

Every mapping shown was judged rather than inferred from wording similarity, and the ones that failed review are published too. See the coverage reports and what was rejected.

Other controls in Standard 10: Specimen testing – Australia National Pathology Standards (First Edition 2027)

Query this from an agent

The graph holds this control, the 1 it maps to, and the evidence behind each claim, over MCP and REST.